These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 1724640)

  • 1. Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease.
    Fleisch H
    Drugs; 1991 Dec; 42(6):919-44. PubMed ID: 1724640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pamidronate. A review of its use in the management of osteolytic bone metastases, tumour-induced hypercalcaemia and Paget's disease of bone.
    Coukell AJ; Markham A
    Drugs Aging; 1998 Feb; 12(2):149-68. PubMed ID: 9509293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonates: preclinical aspects and use in osteoporosis.
    Fleisch HA
    Ann Med; 1997 Feb; 29(1):55-62. PubMed ID: 9073324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates: a new class of drugs in diseases of bone and calcium metabolism.
    Fleisch H
    Recent Results Cancer Res; 1989; 116():1-28. PubMed ID: 2669065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacology and therapeutic utility of bisphosphonates.
    Lourwood DL
    Pharmacotherapy; 1998; 18(4):779-89. PubMed ID: 9692651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonates: the first 40 years.
    Russell RG
    Bone; 2011 Jul; 49(1):2-19. PubMed ID: 21555003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pamidronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.
    Fitton A; McTavish D
    Drugs; 1991 Feb; 41(2):289-318. PubMed ID: 1709854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonates and the treatment of bone disease in the elderly.
    Johansen A; Stone M; Rawlinson F
    Drugs Aging; 1996 Feb; 8(2):113-26. PubMed ID: 8845585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonates in the treatment of osteoporosis.
    Bell NH; Johnson RH
    Endocrine; 1997 Apr; 6(2):203-6. PubMed ID: 9225137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New bisphosphonates in osteoporosis.
    Fleisch H
    Osteoporos Int; 1993; 3 Suppl 2():S15-22. PubMed ID: 8481594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonates: from the laboratory to the clinic and back again.
    Russell RG; Rogers MJ
    Bone; 1999 Jul; 25(1):97-106. PubMed ID: 10423031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of action of the bisphosphonates.
    Fleisch H
    Medicina (B Aires); 1997; 57 Suppl 1():65-75. PubMed ID: 9567358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolving role of bisphosphonates.
    Theriault RL; Hortobagyi GN
    Semin Oncol; 2001 Jun; 28(3):284-90. PubMed ID: 11402438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental basis for the use of bisphosphonates in Paget's disease of bone.
    Fleisch H
    Clin Orthop Relat Res; 1987 Apr; (217):72-8. PubMed ID: 3549097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonates in bone diseases.
    Sparidans RW; Twiss IM; Talbot S
    Pharm World Sci; 1998 Oct; 20(5):206-13. PubMed ID: 9820883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New bisphosphonates in the treatment of bone diseases.
    Gatti D; Adami S
    Drugs Aging; 1999 Oct; 15(4):285-96. PubMed ID: 10582775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonates in the treatment of disorders of mineral metabolism.
    Singer FR; Minoofar PN
    Adv Endocrinol Metab; 1995; 6():259-88. PubMed ID: 7671099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trials with bisphosphonates.
    Lombardi A; Santora AC
    Ann Ital Med Int; 1992; 7(3 Suppl):158S-165S. PubMed ID: 1297394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic bone disease and tumour-induced hypercalcaemia: the role of bisphosphonates.
    Heatley S
    Int J Palliat Nurs; 2001 Jun; 7(6):301-2, 304-7. PubMed ID: 12066026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.
    Plosker GL; Goa KL
    Drugs; 1994 Jun; 47(6):945-82. PubMed ID: 7521833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.